MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 83 filers reported holding MINERVA NEUROSCIENCES INC in Q2 2017. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,000 | +20.0% | 2,206 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -28.6% | 2,206 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -12.5% | 2,206 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -38.5% | 2,206 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $13,000 | -18.8% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | -5.9% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $17,000 | +41.7% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | -29.4% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $17,000 | +13.3% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $15,000 | -46.4% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $28,000 | +55.6% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | +28.6% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $14,000 | +7.7% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $13,000 | 0.0% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | -35.0% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | +100.0% | 2,206 | +77.0% | 0.00% | – |
| Q1 2017 | $10,000 | – | 1,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |